{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:07:12Z","timestamp":1788883632929,"version":"build-2803163510"},"reference-count":71,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2025,10,3]]},"DOI":"10.1080\/13543784.2025.2573638","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:29:06Z","timestamp":1760333346000},"page":"793-802","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["An update on novel investigational agents for the treatment of primary biliary cholangitis"],"prefix":"10.1080","volume":"34","author":[{"given":"Annarosa","family":"Floreani","sequence":"first","affiliation":[{"name":"Hospitalization and Healthcare","place":["Verona, Italy"]},{"name":"University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gabbia","sequence":"additional","affiliation":[{"name":"University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"De Martin","sequence":"additional","affiliation":[{"name":"University of Padova","place":["Padova, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01303-5"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9151525"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep25906"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2022.06.008"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2023.2242771"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(87)91610-2"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(03)00135-1"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.029"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290603"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.003"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.216"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.061"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15592"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000529"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10102464"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509840"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30094-9"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.08.054"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003029"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14906"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100544"},{"key":"e_1_3_2_25_1","first-page":"31A","article-title":"The nonsteroidal farnesoid X receptor (FXR) agonist cilofexor improves liver biochemistry in patients with primary biliary cholangitis (PBC): a phase 2, randomized, placebo-controlled trial","volume":"70","author":"Kowdley KV","year":"2019","unstructured":"Kowdley KV, Minuk GY, Pagadala MR, et al. The nonsteroidal farnesoid X receptor (FXR) agonist cilofexor improves liver biochemistry in patients with primary biliary cholangitis (PBC): a phase 2, randomized, placebo-controlled trial. Hepatology. 2019;70:31A\u201332A.","journal-title":"Hepatology"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14490"},{"issue":"1","key":"e_1_3_2_27_1","first-page":"Abstr 1242","article-title":"Final data of the phase 2 INTREPID study with EDP-305, a non-bile acid farnesoid X receptor (FXR) agonist","volume":"72","author":"Kowdley KV","year":"2020","unstructured":"Kowdley KV, Bonder A, Heneghan MA, et al. Final data of the phase 2 INTREPID study with EDP-305, a non-bile acid farnesoid X receptor (FXR) agonist. Hepatology. 2020;72(Suppl 1):Abstr 1242.","journal-title":"Hepatology"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000612"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.023"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002238"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714519"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.10.001"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.010"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11060372"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14172"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13747"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13859"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002868"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306185"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312100"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16222"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.025"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12878"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177847"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00044.2005"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.009"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom12060823"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15596"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020117-044010"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2022-001001"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.01.020"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01979-1"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.011"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2025.100283"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1170"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.04.005"},{"key":"e_1_3_2_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28359"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051883"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2022.09.001"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15982"},{"key":"e_1_3_2_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2025.01.052"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30319-7"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.10.032"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3103"},{"key":"e_1_3_2_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2024.100596"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-25214-0"},{"issue":"1","key":"e_1_3_2_67_1","first-page":"Abs 4347","article-title":"Volixibat for cholestatic pruritus in primary biliary cholangitis: an adaptive, randomized, placebo-controlled phase 2b trial (VANTAGE): interim results","volume":"80","author":"Kowdley KV","year":"2024","unstructured":"Kowdley KV, Shiffman ML, Weinstein D, et al. Volixibat for cholestatic pruritus in primary biliary cholangitis: an adaptive, randomized, placebo-controlled phase 2b trial (VANTAGE): interim results. Hepatology. 2024;80(S1):Abs 4347.","journal-title":"Hepatology"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2007.01080.x"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15782"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.03.012"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.02.005"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16336"},{"key":"e_1_3_2_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231172829"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2025.2573638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T16:37:57Z","timestamp":1763138277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2025.2573638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,3]]}},"alternative-id":["10.1080\/13543784.2025.2573638"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2025.2573638","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}